Skip to main content
. Author manuscript; available in PMC: 2016 Aug 25.
Published in final edited form as: J Gastrointest Surg. 2013 May 29;17(8):1359–1369. doi: 10.1007/s11605-013-2223-4

Figure 5.

Figure 5

Median overall survival of trimodality eligible patients with locally advanced esophageal adenocarcinoma that achieved a clinical response to neoadjuvant therapy treated with chemoradiation followed by surgery compared to definitive chemoradiation (n=86)